Legal & Disclaimers
**i-Health, Inc. provides access to publicly available news for informational purposes only, and does not necessarily agree with or endorse the information provided in these articles and stories, and is in no way comparing, contrasting, or otherwise stating any reference to these articles and any relation to our products for any purpose.
‡ Based on custom Nielsen US XAOC, 52 W/E 4/18/2026.
† Based on a 2025 Pharmacy Times Survey (Women’s Health/Menopause Supplements Category)
†† Estroven® does not contain synthetic, animal, or human derived hormones. (Sleep Cool® does not contain animal, or human derived hormones).
§ Compared to placebo per the Menopause Rating Scale (MRS)
^ Faster vs. other Estroven® products.
▼ Results based on clinical studies.
▲ Based on a clinical study after 12 weeks of use.
￭ Compared to baseline per the Menopause Rating Scale (MRS) after 12 weeks of use.
◆ Compared to baseline as measured by the Hamilton Anxiety Scale after 12 weeks.
∆ A confirmed menopause stage diagnosis can only be made by a physician after all clinical and laboratory findings have been evaluated.
† Clinically shown to relieve all menopause symptoms tested per Menopause Rating Scale (MRS II) questionnaire.
◊ With continued use/When used as directed
Estroven®, Sleep Cool® Culturelle®, AZO®, and Lactéol® are trademarks of dsm-firmenich group.
Cissus quandrangularis CQR-300® proprietary extract is a registered trademark of Gateway Health Alliances, Inc. US PATENT 8,318,213.
Univestin® is a licensed trademark owned by Unigen, Inc.
Estroven® products are distributed by i-Health, Inc.
